Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Myeloid leukaemia
ADR ID BADD_A02929
ADR Hierarchy
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.01      Leukaemias
16.01.08      Leukaemias myeloid NEC
16.01.08.001      Myeloid leukaemia
01      Blood and lymphatic system disorders
01.10      Leukaemias
01.10.08      Leukaemias myeloid NEC
01.10.08.001      Myeloid leukaemia
Description Form of leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors (MYELOID PROGENITOR CELLS) in the bone marrow and other sites. [MeSH]
MedDRA Code 10028549
MeSH ID D007951
ADR Severity Grade (FAERS) Not Available
ADR Severity Grade (CTCAE) Not Available
Synonym
Leukaemia myelogenous | Leukaemia myeloid | Leukemia myelogenous | Leukemia myeloid | Myeloblastic leukaemia | Myeloblastic leukemia | Myelocytic leukaemia | Myelocytic leukemia | Myeloid leukaemia | Myeloid leukaemia NOS | Myeloid leukaemia, subacute | Myeloid leukemia | Myeloid leukemia NOS | Myeloid leukemia, subacute | Other myeloid leukaemia | Other myeloid leukemia | Other myeloid leukemia without mention of remission | Subacute myeloid leukaemia | Subacute myeloid leukemia without mention of remission | Unspecified myeloid leukaemia | Unspecified myeloid leukemia | Unspecified myeloid leukemia without mention of remission | Subacute myeloid leukemia | Subacute myeloid leukaemia without mention of remission | Unspecified myeloid leukaemia without mention of remission | Leukemia, Myeloid | Leukemia, Granulocytic | Myeloid Leukemia | Leukemias, Myeloid | Myeloid Leukemias | Leukemia, Myelogenous | Leukemias, Myelogenous | Myelogenous Leukemias | Myelocytic Leukemia | Myelogenous Leukemia | Granulocytic Leukemia | Granulocytic Leukemias | Leukemias, Granulocytic | Leukemia, Myelocytic | Leukemias, Myelocytic | Myelocytic Leukemias | Leukemia, Monocytic, Chronic | Monocytic Leukemia, Chronic | Chronic Monocytic Leukemia | Chronic Monocytic Leukemias | Leukemia, Chronic Monocytic | Leukemias, Chronic Monocytic | Monocytic Leukemias, Chronic
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00195Azathioprine--
BADD_D00494Clodronic acid--
BADD_D00549Cyclophosphamide--
BADD_D00723Doxorubicin--
BADD_D00871Felbamate--
BADD_D00914Fludarabine0.000112%
BADD_D01136Imatinib0.000112%
BADD_D01253Lenalidomide0.000241%
BADD_D01601Olaparib0.000168%
BADD_D01978Ruxolitinib0.000137%
BADD_D02002Selegiline--
BADD_D02150Temozolomide--
BADD_D02203Thiotepa--
BADD_D02345Venetoclax0.000112%
BADD_D02517Enasidenib0.000246%
The 1th Page    1    Total 1 Pages
ADReCS-Target
ADR Term Drug Name Target